a Division of Infection Medicine, Department of Clinical Sciences , Lund University, Biomedical Center , Tornavägen 10, SE Lund , Sweden.
b Division of Respiratory Medicine and Allergology, Department of Clinical Sciences , Lund University, Biomedical Center , Tornavägen 10, SE Lund , Sweden.
Virulence. 2018 Dec 31;9(1):724-737. doi: 10.1080/21505594.2018.1441589.
Coagulation, complement, and innate immunity are tightly interwoven and form an alliance that can be traced back to early eukaryotic evolution. Here we employed an ecoimmunological approach using Tissue Factor Pathway Inhibitor (TFPI)-1-derived peptides from the different classes of vertebrates (i.e. fish, reptile, bird, and mammals) and tested whether they can boost killing of various human bacterial pathogens in plasma. We found signs of species-specific conservation and diversification during evolution in these peptides that significantly impact their antibacterial activity. Though all peptides tested executed bactericidal activity in mammalian plasma (with the exception of rodents), no killing was observed in plasma from birds, reptiles, and fish, pointing to a crucial role for the classical pathway of the complement system. We also observed an interference of these peptides with the human intrinsic pathway of coagulation though, unlike complement activation, this mechanism appears not to be evolutionary conserved.
凝血、补体和先天免疫紧密交织,形成了一种可以追溯到早期真核生物进化的联盟。在这里,我们采用生态免疫学方法,使用来自不同脊椎动物(即鱼类、爬行动物、鸟类和哺乳动物)的组织因子途径抑制剂(TFPI)-1 衍生肽,并测试它们是否可以增强血浆中各种人类细菌病原体的杀伤作用。我们发现,在这些肽的进化过程中存在着物种特异性的保守和多样化,这显著影响了它们的抗菌活性。虽然所有测试的肽在哺乳动物血浆中都具有杀菌活性(除了啮齿动物),但在鸟类、爬行动物和鱼类的血浆中没有观察到杀伤作用,这表明补体系统的经典途径起着至关重要的作用。我们还观察到这些肽与人类内在凝血途径相互干扰,尽管与补体激活不同,这种机制似乎没有进化上的保守性。